CurifyLabs Revenue and Competitors
Estimated Revenue & Valuation
- CurifyLabs's estimated annual revenue is currently $6.8M per year.
- CurifyLabs's estimated revenue per employee is $201,000
- CurifyLabs's total funding is $5M.
Employee Data
- CurifyLabs has 34 Employees.
- CurifyLabs grew their employee count by 26% last year.
CurifyLabs's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Product Owner / Pharmaceutical Specialist | Reveal Email/Phone |
3 | Head Hardware Development | Reveal Email/Phone |
4 | Key Account Manager | Reveal Email/Phone |
5 | Quality Manager | Reveal Email/Phone |
6 | Quality Manager | Reveal Email/Phone |
7 | Formulation scientist | Reveal Email/Phone |
CurifyLabs Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $63.9M | 318 | 13% | N/A | N/A |
#6 | $29.9M | 149 | 13% | N/A | N/A |
#7 | $1.7M | 17 | -6% | $114.3M | N/A |
#8 | $6.8M | 34 | -6% | N/A | N/A |
#9 | $12.5M | 62 | -9% | N/A | N/A |
#10 | $7.6M | 41 | -13% | $123.9M | N/A |
What Is CurifyLabs?
CurifyLabs is a Finnish healthtech company developing solutions for manufacturing personalized medicines in pharmacies and hospitals. CurifyLabs' automated on-demand manufacturing concept, “the Pharma Kit” and printable pharmaceutical inks, enable personalized mass customization of medicines, allowing patient safety and efficacy at a significantly lower cost. CurifyLabs was founded in 2021 by Charlotta Topelius and Niklas Sandler Topelius.
keywords:N/A$5M
Total Funding
34
Number of Employees
$6.8M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.8M | 34 | 26% | N/A |
#2 | $3.3M | 34 | 21% | N/A |
#3 | $3.9M | 34 | N/A | N/A |
#4 | $3.3M | 34 | 17% | $5M |
#5 | $7.5M | 34 | -11% | N/A |